foxo4-dri peptide senolytic mouse study 2023 2024

foxo4-dri peptide senolytic mouse study 2023 2024 The disordered p53 transactivation domain is the target of FOXO4 and the compound Peptide targeting senescent cells restores

Name: foxo4-dri peptide senolytic mouse study 2023 2024 The disordered p53 transactivation domain is the target of FOXO4 and the compound Peptide targeting senescent cells restores
Brand: metron-ms.com
SKU: 6717436011
Price: 21.64 USD
Availability: InStock
Rating: 4.396 (12 reviews)

Peptide targeting senescent cells restores stamina, fur, and kidney function in old mice The costs and benefits of senotherapeutics for human health The Lancet Healthy Longevity FOXO4 DRI improves spermatogenesis in aged mice through reducing senescence associated secretory phenotype secretion from Leydig cells ScienceDirect Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells eBioMedicine Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway

SKU: 6717436011 · From metron-ms.com

4.4

USD21.64 USD64.64

Pay in 4 interest-free payments of $5.41 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 3 - Aug 8

Description

17 yrsCN4.8/5.0 18% Reorder rate 69 Interested customers 1/1 Matches all Hot Supplier Lavender Nasal Stick Inhaler Pure Essential Oil Double-End Nose Stick with Wicks Pure Natural Plant Easy Breath $0.65-0.70 Min

7.3.2 Functional validation of epigenetic modifications 7.3.2.1 CRISPR-based epigenetic editing CRISPR/dCas9-mediated epigenetic editing provides powerful tools to reverse or confirm EED-induced DNA methylation changes (143)